He said they had already commenced bilateral talks with manufacturing companies and countries that had developed solutions.
He, however, identified the delicateness of storage of some types of vaccines and cost of storage as some of the factors being considered in shopping for the products.
“We have a technical working group working on the question of the vaccine. We have signed up with the World Health Organisation and GAVI for access to vaccines immediately they are available. But you know that these vaccines are new and the producers are, first of all, not giving any indemnity.
“The big countries where these vaccines are manufactured are of course giving themselves the priority to serve their own citizens first and we hope that the pressure from the World Health Organisation and GAVI (Global Alliance for Vaccines and Immunisation) will be able to get a reserve for other countries which themselves are not manufacturing and be able to attend to what we signed up to; we signed